CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-12 | TURKEL CATHERINE C. President | Purchase | +16,632 | $5.02 | $83K | 78,199 |
| 2018-09-11 | TURKEL CATHERINE C. President | Purchase | +17,048 | $4.56 | $78K | 61,567 |
| 2018-09-05 | TURKEL CATHERINE C. President | Purchase | +805 | $3.97 | $3K | 805 |
| 2017-05-10 | FLESHER GREGORY J. Chief Executive Officer | Purchase | +58,959 | $9.99 | $589K | 115,856 |
| 2017-05-10 | TURKEL CATHERINE C. Chief Development Officer | Purchase | +11,111 | $9.99 | $111K | 24,519 |
| 2017-05-10 | OCAMPO CHRISTINE | Purchase | +10,010 | $9.99 | $100K | 21,590 |
| 2016-03-15 | Buckley Stephen Jr. Director | Purchase | +8,000 | $5.74 | $46K | 11,000 |
| 2015-11-11 | Buckley Stephen Jr. Director | Purchase | +3,000 | $11.25 | $34K | 3,000 |
| 2014-09-22 | Satter Muneer A 10% owner | Purchase | +150,000 | $15.00 | $2.3M | 1,771,688 |
| 2014-09-22 | Apple Tree Partners II - Annex, L.P. Director | Purchase | +237,500 | $15.00 | $3.6M | 3,568,438 |
| 2014-09-22 | Harrison Seth Loring Director | Purchase | +362,500 | $15.00 | $5.4M | 7,912,079 |
| 2014-09-22 | Novartis Bioventures Ltd 10% owner | Purchase | +325,000 | $15.00 | $4.9M | 4,644,328 |
Page 2 of 2 · 32 trades